🔗 Visit the ClinicalTrials.gov page for NCT00795301
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Preoperative versus postoperative chemoradiotherapy for rectal cancer. | N Engl J Med | 2004 | 25.68 |
| 2 | KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. | Cancer Res | 2006 | 13.98 |